Skip to main content
PhiChem Corporation logo

PhiChem Corporation — Investor Relations & Filings

Ticker · 300398 ISIN · CNE100001XV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,231 across all filing types
Latest filing 2022-12-30 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300398

About PhiChem Corporation

https://www.phichem.com.cn

PhiChem Corporation specializes in the research, development, and manufacturing of high-performance materials, with a primary focus on UV-curable products. The company is a leading global supplier of ultraviolet (UV) curable coatings for optical fibers and cables, supporting telecommunications infrastructure. Its product portfolio extends to electronic materials, including photoresists, solder masks, and specialty chemicals used in the fabrication of printed circuit boards (PCBs), integrated circuits, and semiconductor packaging. Additionally, PhiChem provides advanced materials for the display industry, such as liquid crystal materials and functional coatings. By leveraging expertise in polymer chemistry and precision formulation, the company serves diverse high-tech sectors, emphasizing innovation in material science to meet the evolving demands of the global electronics and communications markets.

Recent filings

Filing Released Lang Actions
国元证券股份有限公司关于上海飞凯材料科技股份有限公司部分募集资金投资项目重新论证并暂缓实施的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed statement from Guoyuan Securities regarding the re-evaluation and temporary suspension of certain fundraising investment projects by Shanghai Feikai Materials Technology Co., Ltd. It discusses the use of funds raised through convertible bonds, the reasons for suspending a specific project, the re-assessment process, and approvals by the board, supervisory committee, independent directors, and the sponsor institution. The document references regulatory guidelines related to fundraising and investment project management. It is not a full financial report, earnings release, or audit report, but rather a regulatory disclosure about the status and management of fundraising investment projects. The document length is 3290 characters, which is relatively short but contains substantive content about fundraising project management and regulatory compliance. This fits best under Regulatory Filings (RNS), as it is a compliance and regulatory disclosure that does not fit other specific categories like Capital/Financing Update (CAP) or Audit Report (AR).
2022-12-30 Chinese
关于拟认购上海半导体装备材料产业投资基金II期（筹）暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the company's proposed subscription to an investment fund and related party transactions. It includes information about the fund, the investment amount, associated risks, approvals by the board and supervisory committee, independent directors' opinions, and intermediary verification. The document is a formal announcement of a capital investment and related party transaction, not a financial report or earnings release. It does not contain financial statements or earnings data but focuses on the company's financing activity and related governance procedures. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (6418 characters) and content confirm it is a full announcement rather than a brief notice or a report publication announcement.
2022-12-30 Chinese
国元证券股份有限公司关于上海飞凯材料科技股份有限公司拟认购上海半导体装备材料产业投资基金II期（筹）暨关联交易事项的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed verification opinion from the sponsor institution (Guoyuan Securities Co., Ltd.) regarding Shanghai Feikai Materials Technology Co., Ltd.'s proposed subscription to the Shanghai Semiconductor Equipment Materials Industry Investment Fund II (preparation) and related party transactions. It includes extensive information about the fund, the related parties, the transaction's pricing policy, approvals by the board and supervisory committee, independent directors' opinions, and the sponsor's final verification opinion. The document is regulatory in nature, focusing on compliance with securities regulations and internal governance for a related party transaction and investment fund subscription. It does not contain financial statements, earnings data, or detailed financial analysis typical of annual or interim reports. It is not a report publication announcement since it is substantive and over 5,000 characters. It is not a management report or earnings release. The document is best classified as a Regulatory Filing (RNS) because it is a compliance and disclosure document related to a corporate transaction and regulatory requirements, without being a formal financial report or announcement of voting results, capital changes, or other specific categories.
2022-12-30 Chinese
国元证券股份有限公司关于上海飞凯材料科技股份有限公司2022年度持续督导培训情况报告
Regulatory Filings Classification · 90% confidence The document is a report from a sponsoring securities company about a 2022 annual continuous supervision training conducted for a listed company. It details the training content, participants, and outcomes related to regulatory compliance and information disclosure. The document is short (785 characters) and focuses on a specific training event rather than financial results, management changes, or regulatory filings. It does not contain financial statements or earnings data, nor is it an announcement of voting results or capital changes. It is a specialized report related to regulatory compliance training by the sponsor. This type of document does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is best classified under Regulatory Filings (RNS) as a miscellaneous regulatory compliance report that does not fit other categories.
2022-12-30 Chinese
独立董事关于第四届董事会第三十五次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding a specific board meeting agenda item about a related party transaction and investment proposal. It references compliance with company law, stock exchange rules, and internal company regulations. The content focuses on board-level approval and governance matters rather than financial results, audit opinions, or shareholder voting outcomes. The document length is short (752 characters) and it is not a report or announcement of a report publication. It is not a certification or legal proceeding update. The document fits best under Board/Management Information (MANG) as it relates to board meeting matters and director opinions on corporate governance and transactions.
2022-12-30 Chinese
关于签订募集资金三方监管协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the signing of a tripartite supervision agreement for raised funds related to a convertible bond issuance. It details the use and management of the raised funds, the opening of a special account, and the roles of the involved parties (the company, the bank, and the sponsor). The document does not contain financial statements or detailed financial performance data. It is a regulatory announcement about fundraising and fund management rather than a full financial report or audit. The document length is 2644 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2022-12-28 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.